IntelGenx is a Montreal-based oral drug delivery company that specializes in developing and manufacturing pharmaceutical oral films utilizing its proprietary VersaFilm® technology. The company offers a range of comprehensive pharmaceutical services to its partners, including R&D, analytical method development, clinical monitoring, IP, and regulatory services. IntelGenx's state-of-the-art manufacturing facility supports lab-scale-to-pilot and commercial-scale production, providing full-service capabilities to its clients. IntelGenx is listed on both the TSX-V and OTC-QX exchanges and has a highly skilled team of professionals.